Skip to main navigation Skip to search Skip to main content

Off-Label Use of COVID-19 Vaccines Was Once Discouraged but Has Become Common Amid New Guidelines

Press/Media: Opinion-Editorial

PeriodNov 21 2025

Media contributions

1

Media contributions

  • TitleOff-Label Use of COVID-19 Vaccines Was Once Discouraged but Has Become Common Amid New Guidelines
    Media name/outletThe Conversation
    Media typeWeb
    Country/TerritoryUnited States
    Date11/21/25
    DescriptionThe authors explore the evolving landscape of off-label usage of COVID-19 vaccines in the United States amid shifting regulatory guidance and public health strategy. “Off-label use” refers to administering an approved vaccine outside the age group, dosage, or indication for which it was explicitly authorized. The authors examine the vaccine approval process generally and explain the current policies of the Centers for Disease Control and Prevention (CDC) as well as guidance offered by medical professional organizations, such as the American Academy of Pediatrics, which continue to broadly recommend the COVID-19 vaccine.
    URLhttps://perma.cc/RC6H-7P94
    PersonsShannon Fyfe, Elizabeth Lanphier
View all 1
View less